213 related articles for article (PubMed ID: 33515675)
21. O-linked-N-acetylglucosamine on extracellular protein domains mediates epithelial cell-matrix interactions.
Sakaidani Y; Nomura T; Matsuura A; Ito M; Suzuki E; Murakami K; Nadano D; Matsuda T; Furukawa K; Okajima T
Nat Commun; 2011 Dec; 2():583. PubMed ID: 22158438
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional regulation of
Qian K; Wang S; Fu M; Zhou J; Singh JP; Li MD; Yang Y; Zhang K; Wu J; Nie Y; Ruan HB; Yang X
J Biol Chem; 2018 Sep; 293(36):13989-14000. PubMed ID: 30037904
[TBL] [Abstract][Full Text] [Related]
23. Structural Divergence in
Ogawa M; Senoo Y; Ikeda K; Takeuchi H; Okajima T
Molecules; 2018 Jul; 23(7):. PubMed ID: 30018219
[TBL] [Abstract][Full Text] [Related]
24. Glycoproteomics of NOTCH1 EGF repeat fragments overexpressed with different glycosyltransferases in HEK293T cells reveals insights into O-GlcNAcylation of NOTCH1.
Tsukamoto Y; Ogawa M; Yogi K; Tashima Y; Takeuchi H; Okajima T
Glycobiology; 2022 Jun; 32(7):616-628. PubMed ID: 35290457
[TBL] [Abstract][Full Text] [Related]
25. Antibodies that detect O-linked β-D-N-acetylglucosamine on the extracellular domain of cell surface glycoproteins.
Tashima Y; Stanley P
J Biol Chem; 2014 Apr; 289(16):11132-11142. PubMed ID: 24573683
[TBL] [Abstract][Full Text] [Related]
26. O-GlcNAcylation is increased in prostate cancer tissues and enhances malignancy of prostate cancer cells.
Gu Y; Gao J; Han C; Zhang X; Liu H; Ma L; Sun X; Yu W
Mol Med Rep; 2014 Aug; 10(2):897-904. PubMed ID: 24865644
[TBL] [Abstract][Full Text] [Related]
27. EOGT and
Varshney S; Stanley P
Biochem Soc Trans; 2017 Apr; 45(2):401-408. PubMed ID: 28408480
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic potential of SHCBP1 inhibitor AZD5582 in pancreatic cancer treatment.
Ma Z; Gu Q; Dai Y; Wang Q; Shi W; Jiao Z
Cancer Sci; 2024 Mar; 115(3):820-835. PubMed ID: 38151993
[TBL] [Abstract][Full Text] [Related]
29. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
[TBL] [Abstract][Full Text] [Related]
30. HSF1 Increases EOGT-Mediated Glycosylation of Notch1 to Promote IL-1β-Induced Inflammatory Injury of Chondrocytes.
Huang Y; Pan W; Bao H; Sun X; Xu C; Ma J
Cartilage; 2024 Feb; ():19476035241229211. PubMed ID: 38366389
[TBL] [Abstract][Full Text] [Related]
31. SHCBP1 is over-expressed in breast cancer and is important in the proliferation and apoptosis of the human malignant breast cancer cell line.
Feng W; Li HC; Xu K; Chen YF; Pan LY; Mei Y; Cai H; Jiang YM; Chen T; Feng DX
Gene; 2016 Aug; 587(1):91-7. PubMed ID: 27129942
[TBL] [Abstract][Full Text] [Related]
32. Intracellular and extracellular O-linked N-acetylglucosamine in the nervous system.
Ogawa M; Sawaguchi S; Kamemura K; Okajima T
Exp Neurol; 2015 Dec; 274(Pt B):166-74. PubMed ID: 26278182
[TBL] [Abstract][Full Text] [Related]
33. Contribution of extracellular O-GlcNAc to the stability of folded epidermal growth factor-like domains and Notch1 trafficking.
Ogawa M; Tashima Y; Sakaguchi Y; Takeuchi H; Okajima T
Biochem Biophys Res Commun; 2020 May; 526(1):184-190. PubMed ID: 32201074
[TBL] [Abstract][Full Text] [Related]
34. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.
Lynch TP; Ferrer CM; Jackson SR; Shahriari KS; Vosseller K; Reginato MJ
J Biol Chem; 2012 Mar; 287(14):11070-81. PubMed ID: 22275356
[TBL] [Abstract][Full Text] [Related]
35. SHCBP1 is a novel target and exhibits tumor‑promoting effects in gastric cancer.
Dong YD; Yuan YL; Yu HB; Tian GJ; Li DY
Oncol Rep; 2019 Mar; 41(3):1649-1657. PubMed ID: 30592290
[TBL] [Abstract][Full Text] [Related]
36. Kindlin-2 induced by TGF-β signaling promotes pancreatic ductal adenocarcinoma progression through downregulation of transcriptional factor HOXB9.
Zhan J; Song J; Wang P; Chi X; Wang Y; Guo Y; Fang W; Zhang H
Cancer Lett; 2015 May; 361(1):75-85. PubMed ID: 25724625
[TBL] [Abstract][Full Text] [Related]
37. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.
Mi W; Gu Y; Han C; Liu H; Fan Q; Zhang X; Cong Q; Yu W
Biochim Biophys Acta; 2011 Apr; 1812(4):514-9. PubMed ID: 21255644
[TBL] [Abstract][Full Text] [Related]
38. lncRNA
Li N; Yang G; Luo L; Ling L; Wang X; Shi L; Lan J; Jia X; Zhang Q; Long Z; Liu J; Hu W; He Z; Liu H; Liu W; Zheng G
Clin Cancer Res; 2020 Apr; 26(7):1736-1748. PubMed ID: 31831555
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
40. Augmented O-GlcNAcylation of AMP-activated kinase promotes the proliferation of LoVo cells, a colon cancer cell line.
Ishimura E; Nakagawa T; Moriwaki K; Hirano S; Matsumori Y; Asahi M
Cancer Sci; 2017 Dec; 108(12):2373-2382. PubMed ID: 28973823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
